The Effect of Mobile App Home Monitoring on the Number of In-Person Visits Following Ambulatory Surgery

October 6, 2015 updated by: Women's College Hospital

The Effect of Mobile App Home Monitoring on the Number of In-Person Visits Following Ambulatory Surgery: A Randomized Control Trial

This study evaluate if in an ambulatory breast reconstruction patient population at Women's College Hospital (WCH), can we avert in-person follow-up care through the use of mobile app home monitoring compared to conventional, in-person follow-up care in the first 30-days following surgery.

Study Overview

Detailed Description

Women's College Hospital offers specialized surgical procedures, including breast reconstruction. Patients often travel great distances to undergo surgery. The average ambulatory breast reconstruction patient travels 76 km from home to hospital, with the furthest patient coming from 540 km away.

Most patients receiving ambulatory breast reconstruction have a low rate of postoperative events necessitating clinic visits. However, regular follow-up is still considered important in the early post-operative phase. Increasingly, telemedicine is used to overcome the distance patients must travel to receive specialized care. Telemedicine data suggests that mobile monitoring and follow-up care is valued by patients and can reduce costs to society (1-3).

Currently, Women's College Hospital is using a mobile application (QoC Health Inc., Toronto) to complement in-person postoperative follow-up care for breast reconstruction patients.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S1B1
        • Women's College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients undergoing breast reconstruction at Women's College Hospital. They must be able to use a mobile device and communicate in English.

Exclusion Criteria:

  • They must be non-smokers because smokers carry increased rates of complication and both surgeons have a policy to solely operate on non-smokers (minimum smoke-free period of one month leading to surgery). Pain ratings captured in the VAS and QoR9 are important for judging quality of postoperative recovery. Pre-existing pain or an inability to take narcotics would compromise the reliability of these measures. Therefore, patients must not suffer from chronic pain. They must not be taking narcotic (morphine-like) medication for pain on a regular basis. They must not have an allergy to local anesthetics or morphine-like medications.

Accommodation of special populations: Patients with hearing or speaking impairments will be accommodated with the help of translator. The person who regularly attends visits with her will facilitate this, or if no such person is available, we will use a hospital translator. All patients will receive an explanation of the study and the consent form in writing. All material will be understandable by patients with a grade 6 reading level. If our patients have lower than a grade 6 reading level, we will ask them if there is a family member at home who could assist them with the use of the mobile device.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Mobile app follow-up care
The mobile app follow-up group will have no planned in-person follow-up at one- and four weeks postoperative. However, these visits will be replaced with surgical site examination via submitted photos, visual analog scale (VAS) to assess pain, and the quality of recovery-9 (QoR9) questionnaire monitoring. All of this information is submitted via the mobile application (QoC Health Inc. Toronto). Patient will use daily monitoring for two weeks and then weekly monitoring for four weeks. The surgeon will use a wireless interface to access that data and monitor the patient's condition (not in real time). Physicians will summarize the clinical findings recorded by the mobile app at one week and four weeks postoperative using the prototypical "SOAP" note.
The mobile app follow-up care is an application that can be loaded on to a smartphone. It allows the patient to submit photos of their surgical site, VAS pain scores, and QoR9 scores. The information collected is transmitted to members of the surgical team (i.e. the primary surgeon) and used to monitor recovery over the first 30-days following surgery.
Other Names:
  • QoC Health Inc. mobile application
ACTIVE_COMPARATOR: Conventional, in-person follow-up care
Patients in the conventional, in-person follow-up group will have a planned clinic follow-up at one- and 4-weeks postoperative. This is the follow-up schedule currently used by both surgeons. At these scheduled follow-ups, patients will be asked to complete the VAS to assess pain and the QoR9 questionnaire.
This includes a typical in-person visit with the operating surgeon at one- and four-weeks after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The total number of physician visits related to the surgery
Time Frame: 30 days
The total number of physician visits will include visits to the specialist, family physician, and emergency department related to surgery. This data will be captured by patient survey at two- and four-weeks after surgery.
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The total number of health care telephone calls and emails related to the surgery.
Time Frame: 30 days
The total number of health care telephone calls and emails will include specialist, family physician, and emergency services. This data will be captured by patient survey at two- and four-weeks after surgery.
30 days
Number of complications
Time Frame: 30 days
We will record and report all complications occurring within the 30-day period. This was chosen based on literature surrounding postoperative complications in the first 30-days (4). This will be captured by patient survey at two- and four-weeks after surgery.
30 days
Societal and healthcare system costs
Time Frame: 30 days
A societal perspective will be adopted wherein all cost are assessed irrespective of the payer. This perspective was chosen based on the US Panel on Cost-Effectiveness in Health and Medicine recommendations. This recommendation is meant to improve comparability and consistency across studies (5). Furthermore, while a broad societal perspective will be adopted, results will also be presented using a narrower health system perspective that may be of key interest to health administrators and policy decision makers. This alternative perspective focuses on costs borne within the health system and excludes external costs as well as costs borne by patients and their caregivers.
30 days
Patient satisfaction
Time Frame: 30 days
Currently, there are no validated questionnaires that capture patient satisfaction with postoperative care. We have created a post-pilot survey that captures patient satisfaction with the care and information received. All answers are recorded using a 5-point likert scale. This will be captured at four-weeks after surgery. We will also use the QoR-9 scores and pain VAS scores recorded at one- and four-weeks postoperative. Psychometric properties of the QoR9 include convergent validity and discriminant construct validity. There is also good interrater agreement and internal consistency. The test-retest reliability was 0.61 (p<0.0001). The preferred cut-off is 0.7; however, the QoR9 was still favoured over the quality of recovery-40 (QoR40) questionnaire due to its ease of use (< 2 minutes required to complete the survey) (6). This will be captured in both groups at one- and four-weeks after surgery.
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Semple, MD, MSc, University of Toronto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (ACTUAL)

August 1, 2015

Study Completion (ACTUAL)

August 1, 2015

Study Registration Dates

First Submitted

December 12, 2014

First Submitted That Met QC Criteria

December 12, 2014

First Posted (ESTIMATE)

December 17, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

October 7, 2015

Last Update Submitted That Met QC Criteria

October 6, 2015

Last Verified

October 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Use of Mobile App Home Monitoring After Ambulatory Surgery

Clinical Trials on Mobile app follow-up care

3
Subscribe